Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?

J Clin Oncol. 2010 Apr 20;28(12):1977-9. doi: 10.1200/JCO.2009.27.6014. Epub 2010 Mar 22.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Antineoplastic Agents, Alkylating / adverse effects
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / mortality
  • Brain Neoplasms / pathology
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Dacarbazine / administration & dosage
  • Dacarbazine / adverse effects
  • Dacarbazine / analogs & derivatives*
  • Disease Progression
  • Disease-Free Survival
  • Glioma / drug therapy*
  • Glioma / mortality
  • Glioma / pathology
  • Glioma / radiotherapy
  • Glioma / surgery
  • Humans
  • Radiotherapy, Adjuvant
  • Recurrence
  • Temozolomide
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide